Comparative Pharmacology
Head-to-head clinical analysis: AMPHOTEC versus HEAD SHOULDERS CONDITIONER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMPHOTEC versus HEAD SHOULDERS CONDITIONER.
AMPHOTEC vs HEAD & SHOULDERS CONDITIONER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Amphotericin B binds to ergosterol in fungal cell membranes, forming pores that disrupt membrane integrity, leading to leakage of intracellular contents and cell death.
Not applicable; this is a cosmetic conditioner. No pharmacological mechanism.
Initial dose: 0.5 mg/kg intravenously once daily, titrated as tolerated to 5 mg/kg once daily.
Not applicable. Head & Shoulders Conditioner is a cosmetic product for external use on hair and scalp; no systemic dosing.
None Documented
None Documented
Terminal half-life: 24-48 hours (up to 7 days in hepatic impairment). Long half-life allows once-daily dosing.
Not applicable for systemic elimination; local retention on hair/scalp lasts until next wash (typically 24-48 hours).
Biliary/fecal: ~90% unchanged; renal: <10% (mainly as metabolite).
Renal (urine): <1% unchanged; biliary/fecal: <1% as parent compound; majority remains on hair/scalp and is removed via washing and shedding. Systemic absorption negligible.
Category C
Category C
Antifungal
Antifungal/Antidandruff